Funding opportunities
228 live opportunities from Grants.gov, NIH, NSF, and more.
Chemistry & Materials× remove
- Mechanisms and Functional Roles of PARP1 Hyperactivation in CancerNational Cancer InstitutePA-25-301 closes 5/31/2031up to $639,707activenih
- Targeted degradation of glycoimmune checkpoints Siglec-7 and -9 for cancer immunotherapyNational Cancer InstitutePA-25-301 closes 5/31/2031up to $748,410activenih
- Modulating the Action of Cylindrical Proteases to Eliminate Neisseria Gonorrhea and Chlamydia Trachomatis InfectionsNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $799,619activenih
- TARGETING VAV1 SCAFFOLDING AND ENZYMATIC FUNCTIONS IN MULTIPLE SCLEROSIS VIA BRAIN-PENETRANT MOLECULAR GLUE DEGRADERSNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $798,854activenih
- Delineating the role of 5’ untranslated regions in prostate cancer clonalityNational Cancer InstitutePA-25-301 closes 5/31/2031up to $723,547activenih
- Mechanisms of Action and Resistance of FDA-approved Antifungals Targeting Fungal beta-(1,3)-Glucan SynthaseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $824,451activenih
- An efficient platform for antibiotic discoveryNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $650,221activenih
- Muscle-dependent integration of innate immunity and metabolism dictates infection susceptibilityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $467,354activenih
- The role of endogenous chimeric mRNA encoded GasderminD fusion proteins in immunityNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $794,886activenih
- Optimization of a novel and effective antiviral agent targeting Zika NS4BNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $627,625activenih
- Identification and inhibition of the novel downstream effectors of mutant Ras for mutant Ras-driven cancer targetingNational Cancer InstitutePA-25-301 closes 5/31/2031up to $693,403activenih
- Computational prediction of anti-cancer drug metabolizing enzymes in the human microbiomeNational Cancer InstitutePA-25-301 closes 5/31/2031up to $747,790activenih
- Signal relay during directed cell migration and inflammation in skinNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $690,883activenih
- Optimization of a novel and effective antiviral agent targeting Zika NS4BNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 5/31/2031up to $139,920activenih
- Atypical Sphingolipids in healthy and diseased liverNational Cancer InstitutePA-25-301 closes 5/31/2031up to $634,062activenih
- Biomimetic Migrating Nanoparticles Targeting Tumor Stroma and Neural Invasion to Improve Pancreatic Cancer Therapy and Pain ControlNational Cancer InstitutePAR-25-106 closes 5/31/2031up to $602,170activenih
- Role of Depp1 in muscle atrophyNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 5/31/2031up to $585,012activenih
- THE INTEGRATED STRESS RESPONSE IN GBM PATHOGENESIS AND RESPONSE TO THERAPYNational Cancer InstitutePA-25-301 closes 5/30/2031up to $659,201activenih
- A novel chemical strategy to harness the tumor specific biochemistry of human kallikrein 2 for prostate cancer theranosticsNational Cancer InstitutePA-25-301 closes 4/30/2031up to $575,178activenih
- Molecular and genetic control of astrocyte developmentNational Institute of Neurological Disorders and StrokePA-25-301 closes 4/30/2031up to $439,069activenih
- Development of transformative antibiotic-sparing therapeuticsNational Institute of Allergy and Infectious DiseasesRFA-AI-24-074 closes 4/30/2031up to $716,998activenih
- Chemical Mixture Exposures in Early Life: Impacts on Executive Function and Neural Circuitry Across AdolescenceNational Institute of Environmental Health SciencesPA-25-301 closes 4/30/2031up to $815,546activenih
- Chromatin Signaling Mechanisms in Metabolic Aging and DiseaseNational Institute on AgingPA-20-185 closes 4/30/2031up to $542,730activenih
- ADAR1 promotes Okazaki fragment maturation and is a target for breast cancer therapyNational Cancer InstitutePA-25-301 closes 4/30/2031up to $589,841activenih
- Illuminating Neuropeptide Modulation of Substance Abuse Withdrawal: Novel Photochemical Tools for Precision ControlNational Institute on Drug AbuseRFA-DA-24-007 closes 4/30/2031up to $462,000activenih